The present invention relates to a method of diagnosing depression (even at an early stage that may precede clinical symptoms), for determining the pharmacoresponse to antidepressants, for managing treatment of psychiatric disorders, including depression, and for treatment of depression in patients. Further provided is a method for screening antidepressants.
METHODS AND COMPOSITIONS FOR BIOMARKERS OF DEPRESSION AND PHARMACORESPONSE